other glp-1 medications Decoding Weight Loss The GLP-1 Agonists and Obesity:

Among 69,221 propensity-matched patients with IBD, those who had received a GLP-1 RA had a 5-year colorectal cancer incidence of 0.2% compared with 0.42% in non-GLP-1 RA users (OR, 0.49), corresponding to a 51% reduction in odds of developing colorectal cancer

Noom combines medication with psychology-based behavior change and coaching, while LifeMD focuses on telehealth medical care and prescription management

That said, its not necessary for results

Zhang X, Shi L, Chen R, Zhao Y, Ren D, Yang X

Final verdict: NOW Prebiotic Fiber with Fibersol-2 is affordable, third-party tested with evidence-based ingredients to back it up